Ngā hua rapu - Song, Ivy

A Pharmacokinetic Bridging Study to Compare Systemic Exposure to Budesonide between Budesonide Oral Suspension and ENTOCORT EC in Healthy Individuals mā Song, Ivy H., Finkelman, Richard D., Lan, Lan

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Evaluation of the Effect of Maribavir on Cardiac Repolarization in Healthy Participants: Thorough QT/QTc Study mā Ilic, Katarina, Song, Ivy, Wu, Jingyang, Martin, Patrick

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Pharmacokinetics of Dolutegravir When Administered With Mineral Supplements in Healthy Adult Subjects mā Song, Ivy, Borland, Julie, Arya, Niki, Wynne, Brian, Piscitelli, Stephen

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effects of Maribavir on P‐Glycoprotein and CYP2D6 in Healthy Volunteers mā Song, Ivy H., Ilic, Katarina, Murphy, Joseph, Lasseter, Kenneth, Martin, Patrick

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

The effect of dolutegravir on the pharmacokinetics of metformin in healthy subjects mā Zong, Jian, Borland, Julie, Jerva, Fred, Wynne, Brian, Choukour, Mike, Song, Ivy

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effect of Fosamprenavir-Ritonavir on the Pharmacokinetics of Dolutegravir in Healthy Subjects mā Song, Ivy, Borland, Julie, Chen, Shuguang, Peppercorn, Amanda, Wajima, Toshihiro, Piscitelli, Stephen C.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effect of Prednisone on the Pharmacokinetics of the Integrase Inhibitor Dolutegravir mā Song, Ivy H., Borland, Julie, Chen, Shuguang, Savina, Paul, Peppercorn, Amanda F., Piscitelli, Stephen

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Safety and Pharmacokinetics of GSK364735, a Human Immunodeficiency Virus Type 1 Integrase Inhibitor, following Single and Repeated Administration in Healthy Adult Subjects mā Reddy, Y. Sunila, Min, Sherene S., Borland, Julie, Song, Ivy, Lin, Jiang, Palleja, Sandra, Symonds, William T.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers mā Min, Sherene, Song, Ivy, Borland, Julie, Chen, Shuguang, Lou, Yu, Fujiwara, Tamio, Piscitelli, Stephen C.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effect of Food on the Pharmacokinetics of the Integrase Inhibitor Dolutegravir mā Song, Ivy, Borland, Julie, Chen, Shuguang, Patel, Parul, Wajima, Toshihiro, Peppercorn, Amanda, Piscitelli, Stephen C.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol mā Song, Ivy H., Borland, Julie, Chen, Shuguang, Wajima, Toshihiro, Peppercorn, Amanda F., Piscitelli, Stephen C.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation mā Song, Ivy, Weller, Steve, Patel, Juhin, Borland, Julie, Wynne, Brian, Choukour, Mike, Jerva, Fred, Piscitelli, Stephen

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effects of Etravirine Alone and with Ritonavir-Boosted Protease Inhibitors on the Pharmacokinetics of Dolutegravir mā Song, Ivy, Borland, Julie, Min, Sherene, Lou, Yu, Chen, Shuguang, Patel, Parul, Wajima, Toshihiro, Piscitelli, Stephen C.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next-generation HIV integrase inhibitor, S/GSK1349572 mā Song, Ivy, Borland, Julie, Chen, Shuguang, Lou, Yu, Peppercorn, Amanda, Wajima, Toshihiro, Min, Sherene, Piscitelli, Stephen C

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients mā Zhang, Jianping, Hayes, Siobhán, Sadler, Brian M, Minto, Ilisse, Brandt, Julie, Piscitelli, Steve, Min, Sherene, Song, Ivy H

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects mā Koteff, Justin, Borland, Julie, Chen, Shuguang, Song, Ivy, Peppercorn, Amanda, Koshiba, Takaaki, Cannon, Courtney, Muster, Heather, Piscitelli, Stephen C

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis mā Gupta, Sandeep K., Hill, Malcolm, Vitanza, Joanne M., Farber, Robert H., Desai, Nirav K., Williams, James, Song, Ivy H.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Pharmacokinetics of Single-Dose Dolutegravir in HIV-Seronegative Subjects With Moderate Hepatic Impairment Compared to Healthy Matched Controls mā Song, Ivy H, Borland, Julie, Savina, Paul M, Chen, Shuguang, Patel, Parul, Wajima, Toshihiro, Peppercorn, Amanda F, Piscitelli, Stephen C

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1–Infected, Antiretroviral Therapy–Naive Subjects mā Letendre, Scott L., Mills, Anthony M., Tashima, Karen T., Thomas, Deborah A., Min, Sherene S., Chen, Shuguang, Song, Ivy H., Piscitelli, Stephen C.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects mā Ross, Lisa L., Song, Ivy H., Arya, Niki, Choukour, Mike, Zong, Jian, Huang, Shu-Pang, Eley, Timothy, Wynne, Brian, Buchanan, Ann M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa